Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice

被引:350
作者
Wheeler, VC
White, JK
Gutekunst, CA
Vrbanac, V
Weaver, M
Li, XJ
Li, SH
Yi, H
Vonsattel, JP
Gusella, JF
Hersch, S
Auerbach, W
Joyner, AL
MacDonald, ME [1 ]
机构
[1] Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA 02129 USA
[2] Massachusetts Gen Hosp, Lab Mol Neuropathol, Charlestown, MA 02129 USA
[3] Emory Univ, Sch Med, Dept Genet & Mol Med, Atlanta, GA 30322 USA
[4] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA
[5] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA
[6] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA
关键词
D O I
10.1093/hmg/9.4.503
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington's disease (HD) is caused by an expanded N-terminal glutamine tract that endows huntingtin with a striatal-selective structural property ultimately toxic to medium spiny neurons. In precise genetic models of juvenile HD, Hdh(Q92) and Hdh(Q111) knock-in mice, long polyglutamine segments change huntingtin's physical properties, producing HD-like in vivo correlates in the striatum, including nuclear localization of a version of the full-length protein predominant in medium spiny neurons, and subsequent formation of N-terminal inclusions and insoluble aggregate. These changes show glutamine length dependence and dominant inheritance with recruitment of wild-type protein, critical features of the altered HD property that strongly implicate them in the HD disease process and that suggest alternative pathogenic scenarios: the effect of the glutamine tract may act by altering interaction with a critical cellular constituent or by depleting a form of huntingtin essential to medium spiny striatal neurons.
引用
收藏
页码:503 / 513
页数:11
相关论文
共 43 条
[1]   Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length [J].
Becher, MW ;
Kotzuk, JA ;
Sharp, AH ;
Davies, SW ;
Bates, GP ;
Price, DL ;
Ross, CA .
NEUROBIOLOGY OF DISEASE, 1998, 4 (06) :387-397
[2]   SCA1 TRANSGENIC MICE - A MODEL FOR NEURODEGENERATION CAUSED BY AN EXPANDED CAG TRINUCLEOTIDE REPEAT [J].
BURRIGHT, EN ;
CLARK, HB ;
SERVADIO, A ;
MATILLA, T ;
FEDDERSEN, RM ;
YUNIS, WS ;
DUVICK, LA ;
ZOGHBI, HY ;
ORR, HT .
CELL, 1995, 82 (06) :937-948
[3]   Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation [J].
Davies, SW ;
Turmaine, M ;
Cozens, BA ;
DiFiglia, M ;
Sharp, AH ;
Ross, CA ;
Scherzinger, E ;
Wanker, EE ;
Mangiarini, L ;
Bates, GP .
CELL, 1997, 90 (03) :537-548
[4]   Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain [J].
DiFiglia, M ;
Sapp, E ;
Chase, KO ;
Davies, SW ;
Bates, GP ;
Vonsattel, JP ;
Aronin, N .
SCIENCE, 1997, 277 (5334) :1990-1993
[5]   HUNTINGTIN IS A CYTOPLASMIC PROTEIN ASSOCIATED WITH VESICLES IN HUMAN AND RAT-BRAIN NEURONS [J].
DIFIGLIA, M ;
SAPP, E ;
CHASE, K ;
SCHWARZ, C ;
MELONI, A ;
YOUNG, C ;
MARTIN, E ;
VONSATTEL, JP ;
CARRAWAY, R ;
REEVES, SA ;
BOYCE, FM ;
ARONIN, N .
NEURON, 1995, 14 (05) :1075-1081
[6]  
Ferrante RJ, 1997, J NEUROSCI, V17, P3052
[7]  
Folstein SE, 1989, HUNTINGTONS DIS DISO
[8]  
Gilmor ML, 1996, J NEUROSCI, V16, P2179
[9]   Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract [J].
Goldberg, YP ;
Nicholson, DW ;
Rasper, DM ;
Kalchman, MA ;
Koide, HB ;
Graham, RK ;
Bromm, M ;
KazemiEsfarjani, P ;
Thornberry, NA ;
Vaillancourt, JP ;
Hayden, MR .
NATURE GENETICS, 1996, 13 (04) :442-449
[10]   The genetic defect causing Huntington's disease: Repeated in other contexts? [J].
Gusella, JF ;
Persichetti, F ;
MacDonald, ME .
MOLECULAR MEDICINE, 1997, 3 (04) :238-246